Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Ensign Peak Advisors Inc

Ensign Peak Advisors Inc lessened its stake in Doximity, Inc. (NASDAQ:DOCS) by 8.9% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 297,715 shares of the company’s stock after selling 28,975 shares during the period. Ensign Peak Advisors Inc’s holdings in Doximity were worth $15,895,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in the stock. D. E. Shaw & Co. Inc. increased its holdings in Doximity by 180.4% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 972,157 shares of the company’s stock valued at $51,903,000 after purchasing an additional 625,467 shares during the last quarter. Cresset Asset Management LLC increased its holdings in Doximity by 24.0% in the 4th quarter. Cresset Asset Management LLC now owns 64,732 shares of the company’s stock valued at $3,456,000 after purchasing an additional 12,538 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new stake in Doximity in the 4th quarter valued at approximately $2,544,000. Cetera Investment Advisers increased its holdings in Doximity by 14.6% in the 4th quarter. Cetera Investment Advisers now owns 8,097 shares of the company’s stock valued at $432,000 after purchasing an additional 1,034 shares during the last quarter. Finally, Brevan Howard Capital Management LP acquired a new stake in Doximity in the 4th quarter valued at approximately $1,806,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Insider Activity at Doximity

In related news, CFO Anna Bryson sold 45,000 shares of the business’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $57.23, for a total value of $2,575,350.00. Following the completion of the sale, the chief financial officer now directly owns 357,165 shares of the company’s stock, valued at $20,440,552.95. The trade was a 11.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kira Scherer Wampler sold 2,000 shares of the business’s stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $56.93, for a total transaction of $113,860.00. Following the completion of the sale, the director now directly owns 16,618 shares of the company’s stock, valued at approximately $946,062.74. This trade represents a 10.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is owned by corporate insiders.

Doximity Price Performance

Shares of DOCS opened at $59.10 on Monday. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $85.21. The stock has a market cap of $11.03 billion, a PE ratio of 59.10, a price-to-earnings-growth ratio of 4.10 and a beta of 1.41. The firm has a fifty day moving average price of $57.99 and a 200 day moving average price of $57.36.

Analysts Set New Price Targets

DOCS has been the subject of several recent research reports. Canaccord Genuity Group raised their price target on shares of Doximity from $60.00 to $71.00 and gave the company a “hold” rating in a research report on Friday, February 7th. Needham & Company LLC raised their price target on shares of Doximity from $65.00 to $82.00 and gave the company a “buy” rating in a research report on Friday, February 7th. Wells Fargo & Company reissued an “equal weight” rating on shares of Doximity in a research report on Friday, February 7th. Piper Sandler raised shares of Doximity from a “neutral” rating to an “overweight” rating and raised their price target for the company from $31.00 to $78.00 in a research report on Friday, February 7th. Finally, Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and raised their price target for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Eleven research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $65.39.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.